The present invention is directed to formulations comprising 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives that modulate the activity of protein kinases ("PKs"). Methods of treating diseases related to abnormal PK activity utilizing the formulations comprising these compounds and methods of making these formulations are also disclosed.

 
Web www.patentalert.com

< Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

< Phosphohalohydrins, process for the production thereof and use thereof

> HIV integrase inhibitors

> Pyrazolopyridines and pyrazolopyridazines as antidiabetics

~ 00286